Surufatinib and Serplulimab Combined With AG Regimen Compare With AG Regimen as Conversion Therapy for Patients With Locally Advanced Pancreatic Cancer (SAGE)
Clinical trial NCT05988372 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05988372
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-23
- Primary completion
- 2023-10-23
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.